Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease.
NAFLD includes a wide spectrum of liver conditions ranging from simple steatosis to …

Non-alcoholic fatty liver disease (NAFLD) has emerged as a global epidemic intricately
linked to the rising tide of obesity and metabolic syndrome. This comprehensive review …

Nonalcoholic fatty liver disease (NAFLD) is the most prevalent chronic liver disease
worldwide that poses a significant threat to human health. Cardiovascular disease (CVD) is …

Background: Nonalcoholic fatty liver disease (NAFLD) is a rapidly growing multisystem
disease with extrahepatic manifestations, including effects on the cardiovascular (CV) …

Background and aim Non-alcoholic fatty liver disease (NAFLD), affecting up to around 30%
of the world's adult population, causes considerable liver-related and extrahepatic morbidity …

Nonalcoholic fatty liver disease is increasingly recognized as a major global health problem.
Intertwined with diabetes, metabolic syndrome, and obesity, nonalcoholic fatty liver disease …

Non-alcoholic fatty liver disease (NAFLD) is a common disease defined by excess fat
deposition in the liver. The course of NAFLD is not fully understood, however, some …

Nonalcoholic fatty liver disease (NAFLD) is prevalent in people with the metabolic syndrome
and type 2 diabetes. Evidence is now accumulating that NAFLD is associated with obesity …

Nonalcoholic fatty liver disease (NAFLD) has emerged as a clear risk factor for
cardiovascular risk. Through its association with metabolic syndrome including insulin …

Nonalcoholic fatty liver disease (NAFLD) is a common form of primary fatty liver almost
universally associated with metabolic risk factors. Histologically, NAFLD is categorized as …